Who Could Benefit from EDTA Chelation Therapy?

Chelation therapy, the use of chelating agents such as Detoxamin EDTA to remove toxic heavy metals from the body, was once looked down upon by a large segment of the medical community as not having been proven to be effective. This is because early clinical studies of chelation therapy were flawed due to using too few subjects, unacceptable study design or scientific bias. But these problems were largely overcome after the publication in the Journal of Advancement in Medicine in 1993 of a study by L.T. Chappell et all, who looked at the effects of chelation therapy on nearly 23,000 patients. Of them, more than 85% showed an objective benefit from chelation therapy. Since that time, the number of success stories has continued to increase.

Unfortunately, the problem of toxins such as heavy metals accumulating in our bodies has also been increasing. We are repeatedly told by environmentalists that planet earth is getting more and more poisoned from the build up of toxins including lead, mercury, aluminum, cadmium, arsenic and others. The adverse effect on human health of these heavy and light metal poisons has become so great that a name has been assigned: Toxic Metal Syndrome. It has been estimated that more than 90% of all the people living in the industrialized world have at least one of the health problems associated with living in a toxic environment.

Listed below are only a few of the behavioral, structural and functional abnormalities linked to three of the most problematic toxic heavy metals:

Mercury - Depression, hallucinations, obsessive-compulsive behavior, chronic fatigue, suicidal and aggressive behavior, anxiety and attention deficit disorder.

Lead - Spinal cord alterations, kidney damage, increased heart rate, suppression of the immune system, birth defects.

Copper - Skin problems such as eczema and rashes, headaches, muscle pain, decreased red blood cell count, cirrhosis of the liver, hepatitis, convulsions and seizures.

Detoxamin EDTA works differently from traditional chelation therapies, in that it does not have to be administered as an intravenous drip in an outpatient environment by trained nurses or other medical personnel. Instead, Detoxamin EDTA is available in a suppository form that can be used in the privacy of one's own home. In severe cases, it is recommended that one suppository be taken every night for 90 days. For less severe cases, such as individuals who are interested in chelation therapy for prevention or anti-aging, Detoxamin should be taken every other night for 180 days. In addition, supplementation with vitamins, minerals and trace minerals should also be taken on a daily basis.

Robert Scheer works as a free lance writer as well as consulting for the Detoxamin EDTA Info web site. For more details go to